B
CVS icon

Bellecapital’s CVS Health CVS Stock Holding History

Bellecapital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-34,186
Closed -$2.24M – 120
2018
Q4 		$2.24M Sell
34,186
-1,411
-4% -$105K 1.6% 21
2018
Q3 		$2.8M Sell
35,597
-3,317
-9% -$237K 1.84% 20
2018
Q2 		$2.5M Buy
38,914
+12,503
+47% +$824K 1.81% 20
2018
Q1 		$1.64M Sell
26,411
-16,049
-38% -$1.15M 1.54% 21
2017
Q4 		$3.08M Buy
42,460
+13,983
+49% +$1.02M 2.49% 17
2017
Q3 		$2.32M Sell
28,477
-23,796
-46% -$1.88M 2.73% 15
2017
Q2 		$4.21M Sell
52,273
-2,108
-4% -$166K 3.69% 11
2017
Q1 		$4.27M Buy
54,381
+1,391
+3% +$111K 3.95% 8
2016
Q4 		$4.18M Buy
+52,990
New +$4.29M 3.72% 10

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bellecapital's CVS Position: Q1 2019 in Review

Bellecapital sold out of CVS Health (CVS) in Q1 2019, closing a stake of 34,186 shares — an estimated $2.24M sold.

Bellecapital first reported a position in CVS in Q4 2016 and held it in 9 quarters. The position peaked at $4.27M in Q1 2017. 1,708 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

  • Bellecapital reported no remaining CVS Health position as of Q1 2019 after selling out during the quarter.
  • Bellecapital sold 34,186 CVS Health shares in Q1 2019, an estimated $2.24M.
  • Bellecapital first reported a position in CVS Health in Q4 2016 and held it in 9 quarters.
  • Bellecapital's CVS Health position peaked at $4.27M in Q1 2017.
  • 1,708 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on Bellecapital's 13F filing for Q1 2019, filed 23 Apr 2019.